Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 90
Selected: 0
NCT IDTitle
NCT05943860Efficacy and Tolerability of Pantovigar® Vegan in Female Subjects With Diffuse Hair Loss
NCT00465738IncobotulinumtoxinA (Xeomin) for Upper Limb Spasticity
NCT03119948Partial Blocks of Rectus Femoris and Soleus With Botulinum Toxin Type A (Xeomin®) to Improve Gait in Hemiparesis
NCT02002884Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Arm(s) or of Arm(s) and Leg(s) in Cerebral Palsy
NCT06381999Validity and Inter-rater Reliability for Early Recognition of Spasticity Using the Decision Tree Tool
NCT01392300Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke
NCT05585398A Study to Evaluate the Distribution of Botulinum Neurotoxin Type A Administered as Intradermal Injections, Comparing Different Doses, Concentrations, and Delivery Methods
NCT01905683Long-term Open-label Study of Botulinumtoxin Type A to Treat Spasticity of Leg(s) or Leg(s) and Arm in Cerebral Palsy
NCT00512135Safety and Efficacy of NT 201 (IncobotulinumtoxinA [Xeomin]) in the Treatment of Glabellar Frown Lines
NCT01261741Investigation of Memantine in the Treatment of Memory, Concentration or Attention Problems
NCT01464307Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Leg After a Stroke
NCT03650387Safety, Effectiveness and Participant Satisfaction Study of a Dermal Filler (of RADIESSE® (+) Lidocaine) in the Treatment of Ageing Signs in the Face
NCT04908423Xeomin® and Gait Related Mobility After Stroke
NCT01486264Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex
NCT00872898Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism
NCT00661440Efficacy and Safety Study of Neramexane to Treat Congenital and Acquired Nystagmus
NCT01714960Safety and Tolerability of MRZ-99030 Eye Drops in Healthy Volunteers and Glaucoma Patients
NCT01910896Effectiveness and Safety Study of Overnight Intensive Patch in Scars
NCT00827008Open-Label, Long-Term Treatment Study, to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients With Subjective Tinnitus
NCT00430963IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines
NCT00432666IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Post-stroke Spasticity of the Upper Limb
NCT00406367IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Blepharospasm
NCT00405886Neramexane for Tinnitus
NCT00407030IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Cervical Dystonia
NCT04177212Investigation of the Effectiveness and Safety of MRZF111 in the Treatment of Décolleté Wrinkles
NCT06995287Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection Via Hysteroscopy in Pelvic Pain Suggestive of Dysmenorrhea
NCT01603459Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and Arm
NCT01565395Incobotulinum Toxin A for Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS)
NCT03986424Local Study of Akatinol Memantine in VaD in Russia
NCT00649220Memantine and Antipsychotics Use
NCT00712283Investigate the Effect of Neramexane Mesylate IR Tablet on Driving Fitness and Capability to Operate Machines in Healthy Volunteers
NCT01515371Dose Finding Study for a Botulinum Toxin Type A Injection to Treat Habitual Snoring
NCT03806933Study to Investigate the Safety and Duration of Effect of Different Botulinum Toxin A (NT 201) Dose Groups Following the Treatment of Glabellar Frown Lines
NCT07018700A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
NCT00624026Memantine - Communication Study
NCT00799942Open-lable Extension Study on Safety and Efficacy of Neramexane to Treat Congenital and Acquired Nystagmus
NCT04210258Post-Market Clinical Follow-up Performance and Safety Study of Etermis 3 and 4 in the Face
NCT00541905Daily Dystonia Practice - A Trial to Investigate NT 201, the Duration of Treatment Effect After One Injection Session and in Long-term Treatment in Cervical Dystonia
NCT00515944Evaluate the Migration Potential of Xeomin® Compared to Two Other Botulinum Toxin Type A Products
NCT01893411Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Leg(s) in Cerebral Palsy
NCT00972127Changes in the Renal Excretion of Neramexane by Acidification of Urinary pH Study With and Without Application of a Urinary pH Acidification Regimen
NCT02091739Clinical Study to Investigate the Efficacy and Safety of Two Dose Levels of NT 201 Versus Placebo in Treating Chronic Troublesome Sialorrhea in Various Neurological Conditions
NCT04075981Prevention Atrial Fibrillation by BOTulinum Toxin Injections (BOTAF)
NCT00694148Safety and Efficacy of NT 201, Free of Complexing Proteins, in the Treatment of Glabellar Frown Lines
NCT02462317Study of the Effects on Motor Recovery of Early Post-stroke Spasticity Treatment
NCT00773591Effect of NT 201 (Botulinum Neurotoxin Type A Free of Complexing Proteins) on Sleep-related Breathing Disorders
NCT04594213Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Lateral Canthal Lines) in Subjects With Moderate to Severe Upper Facial Lines
NCT03256942Evaluation of the Sensitivity of Merz Lips Fullness Assessment Scale Following Etermis 4® Treatment for Lips Volume Augmentation
NCT01686061Blepharospasm Patient Survey for Patients With Blepharospasm
NCT07473635Perineural Incobotulinumtoxin-A for Complex Regional Pain Syndrome - An Open-label Feasibility Study